RESUMO
Objective:To assess the efficacy and safety of Zyrtec drops which is a patent product of UCBpharma in treatment of allergy rhinitis in children. Method :A total of 47 children of both sexes aged between 2 to6 years with allergy rhinitis (AR) were included in this study,who were randomly selected to be treated withZyrtec (Cetirizine 2 HCL) drops 5 mg daily for 3 weeks. Investigators made a global evaluation with symptomscores before treatment and once a week for 3 weeks after treatment. Result:An improvement was shown in eachweek after treatment with statistical significance (P＜0.01). Zyrtec drops provided an excellent improvement atthe end of the study. Tolerance was good. Conclusion :For acting fast ,potent ,good tolerance and convenience inuse,Zyrtec drops is a better treatment in AR in kids.